Anti-inflammatory therapies for chronic prostatitis

European Urology, Supplement

Volumn 2, Issue 2, 2003, Pages 30-33

  Hochreiter, Werner W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anti inflammatory therapy; Chronic pelvic pain syndrome; Chronic prostatitis; Phytotherapy

Indexed keywords

ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CERNITIN; NONSTEROID ANTIINFLAMMATORY AGENT; QUERCETIN;

CHRONIC PROSTATITIS; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DRUG INDICATION; DRUG USE; HUMAN; LEUKOCYTE; MALE; PELVIS PAIN SYNDROME; PHYTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0037335045     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(02)00198-7     Document Type: Conference Paper

References (22)

1. National Institutes of Health Summary Statement. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Workshop on Chronic Prostatitis. Bethesda, MD, 1995.
2. Moon TD. Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis. Urology 1997;50:543-7.
3. Nickel JC, Nigro M, Valiquette L, Anderson P, Patrick A, Mahoney J, et al. Diagnosis and treatment of prostatitis in Canada. Urology 1998;52:797-802.
4. McNaughton Collins M, Fowler Jr FJ, Elliott DB, Albertsen PC, Barry MJ. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? Urology 2000;55:403-7.
5. Meares EMJ. Prostatitis and related disorders. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ, editors. Campbell's urology, 7th ed. Philadelphia: Saunders; 1998.
6. Nickel JC. Prostatitis: evolving management strategies. Urol Clin North Am 1999;26:737-51.
7. de la Rosette JJ, Hubregtse MR, Karthaus HF, Debruyne FM. Results of a questionnaire among Dutch urologists and general practitioners concerning diagnostics and treatment of patients with prostatitis syndromes. Eur Urol 1992;22:14-9.
8. Nickel JC. Prostatitis: myths and realities. Urology 1998;51:362-6.
9. Krieger JN, Nyberg Jr L, Nickel JC. NIH consensus definition and classification of prostatitis. J Am Med Assoc 1999;282:236-7.
10. Krieger JN, Jacobs RR, Ross SO. Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol 2000;164:1554-8.
11. Insel PA. Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In: Gillman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's, The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press; 1990.
12. Persson BE, Ronquist G, Ekblom M. Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study. J Urol 1996;155:961-4.
13. Nickel JC, Siemens DR, Lundie MJ. Allopurinol for prostatitis: where is the evidence? Lancet 1996;347:1711-2.
14. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54:960-3.
15. Shoskes DA. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 1998;66:147-52.
16. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997;24:1680-4.
17. Buck AC, Rees RW, Ebeling L. Treatment of chronic prostatitis and prostatodynia with pollen extract. Br J Urol 1989;64:496-9.
18. Rugendorff EW, Weidner W, Ebeling L, Buck AC. Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 1993;71:433-8.
19. Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W, et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000;56:1025-9.
20. Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998;52:744-9.
21. Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000;164:214-8.
22. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999;54:229-33.